Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Experts
Research Units
Projects
Publications
Spin-Offs
Media
Prizes
Activities
Courses
Search by expertise, name or affiliation
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders
Dermatologic Cooperative Oncology Group (DeCOG)
4
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Ipilimumab
100%
Preexisting Condition Coverage
85%
Melanoma
59%
Thyroiditis
7%
Sarcoidosis
5%
Skin Neoplasms
5%
Ulcerative Colitis
5%
Pancreatitis
5%
Crohn Disease
5%
Immunosuppressive Agents
4%
Safety
3%
Antibodies
3%
Therapeutics
2%